Sarepta Therapeutics, Inc. SRPT Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s total liabilities & equity?
- Sarepta Therapeutics, Inc. (SRPT) reported total liabilities & equity of $3.18B in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s total liabilities & equity changed year-over-year?
- Sarepta Therapeutics, Inc.'s total liabilities & equity decreased by 8.3% year-over-year, from $3.47B to $3.18B.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s total liabilities & equity?
- Over 5 years (2020 to 2025), Sarepta Therapeutics, Inc.'s total liabilities & equity has grown at a 2.3% compound annual growth rate (CAGR), from $2.98B to $3.35B.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.